Arrowstreet Capital’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-504
Closed -$89K 2531
2020
Q3
$89K Buy
+504
New +$89K ﹤0.01% 2261